Summary

Report Scope
The report provides an overview of global cloud computing in cell biology, genomics and drug development, and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on branch of biology, deployment type, application, end user and region. Based on the branch of biology, the market is further segmented into human biology, microbiology, animal biology and plant biology. The market is categorized by deployment type into public cloud, private cloud and hybrid cloud. By application, the market is segmented as discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization. The market is categorized based on end user into pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and others (such as academia, government or agritech). The study covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in each region.
The report also sheds light on developments related to venture capital (VC) and corporate investments, regulatory trends, and enterprise strategies of key firms as well as potential future opportunities stemming from cloud computing in cell biology, genomics, drug development of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis, and tariff assessments makes this report a critical resource for stakeholders, investors, and policymakers seeking to understand and capitalize on the rapidly developing field of cloud computing in cell biology, genomics and drug development. The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It also analyzes emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings of key companies in the cloud computing in cell biology, genomics and drug development market. It also has a dedicated section of company profiles that covers details of leading key market participants.
Report Includes
- 52 data tables and 51 additional tables
- An analysis of the global market for cloud computing applications in cell biology, genomics and drug development
- Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
- Estimates of the market size and revenue growth prospects, along with a market share analysis by the branch of biology, deployment type, application, end user and region
- Facts and figures about market dynamics, opportunities and deterrents, technological advances, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Information about key partnerships between cloud service providers and pharma/biotech companies and investment in the pharmaceutical R&D sector
- A relevant patent analysis, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading companies, including Alphabet Inc. (Google), Amazon Web Services (AWS) Inc., IBM Corp., Microsoft and Oracle Corp.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Technological Advances
Market Dynamics and Growth Factors
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview and Market Definition
Leveraging Cloud Computing for Collaboration
Interactions Between Scalability and Collaboration
Real-Time Applications of Cloud Computing to Achieve Scalability and Collaboration
Porter's Five Forces Model
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Competition in the Industry
Threat of Substitutes
Macroeconomic Factors Analysis
Growth of Biomedical R&D Budgets and Digital Transformation Budgets
Rise of Precision Medicine and Data-Heavy Therapeutics
Scaling Telehealth, Remote Studies and Decentralized Research Models
Impact of the U.S. Tariffs
Overview
Direct Impact: Increased Operational Costs and R&D Expenditure
Strategic and Operational Impacts
Asymmetric Impact: Widening the Gap Between "Haves" and "Have-Nots"
Geopolitical and Long-Term Strategic Shifts
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Explosion of Biological Data - Driving Demand for Scalable Compute and Storage
Rising Adoption of AI and Advanced Analytics in Biology Demands High-Performance Cloud Infrastructure
Increasing Demand for Real-Time, Decentralized Collaboration in Pharmaceutical R&D
Emergence of Cloud-Native Bioinformatics and Lab Informatics Vendors (SaaS Economics)
Market Restraints
Data Security and Privacy
High Costs Associated with Cloud Implementation
Market Opportunities
Integration with Real-World Evidence and Clinical Data
Commercialization of Cloud-Native Bioinformatics as a Service
Chapter 4 Regulatory Landscape
Overview
The United States (U.S.)
European Union (EU)
Japan
China
India
Chapter 5 Emerging Technologies and Developments
Overview
Cloud-Native Bioinformatics and Multiomics Integration
Federated Cloud and Secure Data Sharing
Digital Twins and Synthetic Data in Drug Development
High-Performance Computing (HPC) in the Cloud for Genomics and Biology
AI-Enabled Cloud Manufacturing and Real-World Evidence (RWE)
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Branch of Biology
Human Biology
Microbiology
Animal Biology
Plant Biology
Market Analysis, by Deployment Type
Public Cloud
Private Cloud
Hybrid Cloud
Market Analysis, by Application
Discovery and Preclinical Research
Clinical Trials
Pharma Manufacturing
Plant and Microbial Gene Analysis
Commercialization
Market Analysis, by End User
Pharmaceutical and Biotechnology Companies
Clinical Laboratories
Contract Research Organizations (CROs)
Others (Academia/Govt./Agritech, etc.)
Geographic Breakdown
Market Analysis, by Region
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Patent Review/New Developments
Key Takeaways
Chapter 8 Competitive Landscape
Overview
Key Takeaways
Cloud Computing Market for Cell Biology, Genomics and Drug Development - Major Companies
Chapter 9 Appendix
Methodology
References
Abbreviations
Company Profiles
ALPHABET INC. (GOOGLE INC.)
AMAZON WEB SERVICES INC.
ARISGLOBAL
BENCHLING
BOX
CISCO SYSTEMS INC.
COGNIZANT
DNANEXUS INC.
IBM CORP.
INFORMATICA INC.
MICROSOFT
ORACLE
RESCALE INC.
SALESFORCE INC.
SAP SE

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 1 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
Table 2 : Global Market for Human Biology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 3 : Global Market for Microbiology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 4 : Global Market for Animal Biology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 5 : Global Market for Plant Biology for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 6 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
Table 7 : Global Market for Public Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 8 : Global Market for Private Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 9 : Global Market for Hybrid Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 10 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
Table 11 : Key Cloud Platform Software for Research Data Management and Analysis
Table 12 : Global Market for Discovery and Preclinical Research Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 13 : Global Market for Clinical Trials Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 14 : Global Market for Pharma Manufacturing Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 15 : Global Market for Plant and Microbial Gene Analysis Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 16 : Global Market for Commercialization Applications for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 17 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
Table 18 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
Table 19 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Clinical Laboratories, by Region, Through 2030
Table 20 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Contract Research Organizations, by Region, Through 2030
Table 21 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development for Other End Users, by Region, Through 2030
Table 22 : Global Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Region, Through 2030
Table 23 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, Through 2030
Table 24 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
Table 25 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
Table 26 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
Table 27 : North American Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
Table 28 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, Through 2030
Table 29 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
Table 30 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
Table 31 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
Table 32 : European Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
Table 33 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Country, Through 2030
Table 34 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
Table 35 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
Table 36 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
Table 37 : Asia-Pacific Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
Table 38 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Branch of Biology, Through 2030
Table 39 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Deployment Type, Through 2030
Table 40 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by Application, Through 2030
Table 41 : RoW Market for Cloud Computing in Cell Biology, Genomics and Drug Development, by End User, Through 2030
Table 42 : Analysis of Patents on Cloud Computing in Cell Biology, Genomics and Drug Development Applications, January 2024-September 2025
Table 43 : Global Ranking of Companies in the Cloud Computing Market for Cell Biology, Genomics and Drug Development, 2024
Table 44 : Strategic Developments of Top Companies in Cloud Computing Market for Cell Biology, Genomics and Drug Development, 2025
Table 45 : Information Sources for this Report
Table 46 : Abbreviations Used in this Report
Table 47 : Alphabet Inc. (Google Inc.): Company Snapshot
Table 48 : Alphabet Inc. (Google Inc.): Financial Performance, FY 2023 and 2024
Table 49 : Alphabet Inc. (Google Inc.): Product Portfolio
Table 50 : Alphabet Inc. (Google Inc.): News/Key Developments, 2025
Table 51 : Amazon Web Services Inc.: Company Snapshot
Table 52 : Amazon Web Services Inc.: Financial Performance, FY 2023 and 2024
Table 53 : Amazon Web Services Inc.: Product Portfolio
Table 54 : Amazon Web Services Inc.: News/Key Developments, 2024 and 2025
Table 55 : ArisGlobal: Company Snapshot
Table 56 : ArisGlobal: Product Portfolio
Table 57 : ArisGlobal: News/Key Developments, 2025
Table 58 : Benchling: Company Snapshot
Table 59 : Benchling: Product Portfolio
Table 60 : Benchling: News/Key Developments, 2023-2025
Table 61 : Box: Company Snapshot
Table 62 : Box: Financial Performance, FY 2023 and 2024
Table 63 : Box: Product Portfolio
Table 64 : Box: News/Key Developments, 2024
Table 65 : Cisco Systems Inc.: Company Snapshot
Table 66 : Cisco Systems Inc.: Financial Performance, FY 2023 and 2024
Table 67 : Cisco Systems Inc.: Product Portfolio
Table 68 : Cisco Systems Inc.: News/Key Developments, 2024
Table 69 : Cognizant: Company Snapshot
Table 70 : Cognizant: Financial Performance, FY 2023 and 2024
Table 71 : Cognizant: Product Portfolio
Table 72 : Cognizant: News/Key Developments, 2024 and 2025
Table 73 : DNAnexus Inc.: Company Snapshot
Table 74 : DNAnexus Inc.: Product Portfolio
Table 75 : DNAnexus Inc.: News/Key Developments, 2025
Table 76 : IBM Corp.: Company Snapshot
Table 77 : IBM Corp.: Financial Performance, FY 2023 and 2024
Table 78 : IBM Corp.: Product Portfolio
Table 79 : IBM Corp.: News/Key Developments, 2025
Table 80 : Informatica Inc.: Company Snapshot
Table 81 : Informatica Inc.: Financial Performance, FY 2023 and 2024
Table 82 : Informatica Inc.: Product Portfolio
Table 83 : Informatica Inc.: News/Key Developments, 2024 and 2025
Table 84 : Microsoft: Company Snapshot
Table 85 : Microsoft: Financial Performance, FY 2023 and 2024
Table 86 : Microsoft: Product Portfolio
Table 87 : Microsoft: News/Key Developments, 2024
Table 88 : Oracle: Company Snapshot
Table 89 : Oracle: Financial Performance, FY 2023 and 2024
Table 90 : Oracle: Product Portfolio
Table 91 : Oracle: News/Key Developments, 2024 and 2025
Table 92 : Rescale Inc.: Company Snapshot
Table 93 : Rescale Inc.: Product Portfolio
Table 94 : Rescale Inc.: News/Key Developments, 2024 and 2025
Table 95 : Salesforce Inc.: Company Snapshot
Table 96 : Salesforce Inc.: Financial Performance, FY 2023 and 2024
Table 97 : Salesforce Inc.: Product Portfolio
Table 98 : Salesforce Inc.: News/Key Developments, 2025
Table 99 : SAP SE: Company Snapshot
Table 100 : SAP SE: Financial Performance, FY 2023 and 2024
Table 101 : SAP SE: Product Portfolio
Table 102 : SAP SE: News/Key Developments, 2024 and 2025